Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
Rachel P. Riechelmann(AC Camargo Hospital), Monika K. Krzyzanowska(Sunnybrook Health Science Centre), L. Wang, Nathan Taback(Ontario Institute for Cancer Research), Ian F. Tannock(Princess Margaret Cancer Centre), Everardo D. Saad
Cited by 330
Related Papers
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Associations Between End-of-Life Discussion Characteristics and Care Received Near Death: A Prospective Cohort Study
|Journal of Clinical Oncology|2012|572
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
|British Journal of Cancer|2014|470